title: Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.
abstract: OBJECTIVE
  To describe the pharmacokinetics of phenylbutazone and oxyphenbutazone after IV administration in miniature donkeys.
  
  
  METHODS
  6 clinically normal miniature donkeys.
  
  
  METHODS
  Blood samples were collected before and 5, 10, 20, 30, 45, 60, 90, 120, 180, 240, 300, 360, and 480 minutes after IV administration of phenylbutazone (4.4 mg/kg of body weight). Serum was analyzed in triplicate by use of high-performance liquid chromatography for determination of phenylbutazone and oxyphenbutazone concentrations. The serum concentration-time curve for each donkey was analyzed separately to estimate model-independent pharmacokinetic variables.
  
  
  RESULTS
  Serum concentrations decreased rapidly after IV administration of phenylbutazone, and they reached undetectable concentrations within 4 hours. Values for mean residence time ranged from 0.5 to 3.0 hours (median, 1.1 hour), whereas total body clearance ranged from 4.2 to 7.5 ml/kg/min (mean, 5.8 ml/kg/min). Oxyphenbutazone appeared rapidly in the serum; time to peak concentration ranged from 13 to 41 minutes (mean, 26.4 minutes), and peak concentration in serum ranged from 2.8 to 4.0 mg/ml (mean, 3.5 microg/ml).
  
  
  CONCLUSIONS
  Clearance of phenylbutazone in miniature donkeys after injection of a single dose (4.4 mg/kg, IV) is rapid. Compared with horses, miniature donkeys may require more frequent administration of phenylbutazone to achieve therapeutic efficacy.
authors.affiliation: Texas Veterinary Medical Center, Texas A&M University, College Station 77843, USA.
authors.forename: N S
authors.initials: NS
authors.lastname: Matthews
authors.forename: K E
authors.initials: KE
authors.lastname: Peck
authors.forename: T S
authors.initials: TS
authors.lastname: Taylor
authors.forename: K L
authors.initials: KL
authors.lastname: Mealey
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000097:blood / Q000493:pharmacokinetics*; D019540:Area Under Curve; D018397:Equidae / Q000378:metabolism* / Q000502:physiology; D008297:Male; D010113:Oxyphenbutazone / Q000097:blood / Q000493:pharmacokinetics*; D010653:Phenylbutazone / Q000097:blood / Q000493:pharmacokinetics*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010653:Phenylbutazone; D010113:Oxyphenbutazone